OBJECTIVES: The A10 cell line was derived from the thoracic aorta of embryonic rat and is a commonly used model of vascular smooth muscle cells (VSMC). Despite its wide use this cell line has not been well characterized. This is especially important in light of recent evidence of phenotypically distinct cell populations isolated from rat vascular tissue. Therefore, the present study was undertaken to confirm the VSMC nature of A10 cells and to investigate whether these cells particularly resemble adult, neonatal, or neointimal rat VSMC. METHODS: A variety of defining characteristics were used that included immunofluorescent analysis for smooth muscle alpha-actin, smooth and non-muscle myosin heavy chains, desmin and vimentin; Western analysis for smooth muscle and non-muscle myosin heavy chains; mRNA analysis for smooth muscle myosin heavy chain, calponin, SM22 alpha, tropoelastin and PDGF-B peptide; and functional assays of cell migration, proliferation and agonist induced intracellular Ca transients. RESULTS: A10 cells expressed smooth muscle alpha-actin, SM22 alpha, smooth muscle calponin and vimentin, characteristic of in vivo rat VSMCs; however they also resembled de-differentiated smooth muscle cells in that they expressed non-muscle myosin rather than smooth muscle myosin heavy chain. A10 cells resembled cultured rat neonatal smooth muscle cells ("pup cells") in that they had an epithelioid shape and lacked functional PDGF-alpha receptors: however they did not express PDGF-B mRNA or proliferate in low serum containing medium as do neonatal cells. A10 cells had several characteristics in common with neointimal cells including the expression of alpha-actin, vimentin, and non-muscle myosin and the lack of expression of PDGF-B mRNA as well as the ability to migrate in response to PDGF-BB. CONCLUSION: In conclusion, A10 cells are nondifferentiated VSMC that differ from neonatal but bear significant resemblance to neointimal cells.
OBJECTIVES: The A10 cell line was derived from the thoracic aorta of embryonic rat and is a commonly used model of vascular smooth muscle cells (VSMC). Despite its wide use this cell line has not been well characterized. This is especially important in light of recent evidence of phenotypically distinct cell populations isolated from rat vascular tissue. Therefore, the present study was undertaken to confirm the VSMC nature of A10 cells and to investigate whether these cells particularly resemble adult, neonatal, or neointimal rat VSMC. METHODS: A variety of defining characteristics were used that included immunofluorescent analysis for smooth muscle alpha-actin, smooth and non-muscle myosin heavy chains, desmin and vimentin; Western analysis for smooth muscle and non-muscle myosin heavy chains; mRNA analysis for smooth muscle myosin heavy chain, calponin, SM22 alpha, tropoelastin and PDGF-B peptide; and functional assays of cell migration, proliferation and agonist induced intracellular Ca transients. RESULTS: A10 cells expressed smooth muscle alpha-actin, SM22 alpha, smooth muscle calponin and vimentin, characteristic of in vivo rat VSMCs; however they also resembled de-differentiated smooth muscle cells in that they expressed non-muscle myosin rather than smooth muscle myosin heavy chain. A10 cells resembled cultured rat neonatal smooth muscle cells ("pup cells") in that they had an epithelioid shape and lacked functional PDGF-alpha receptors: however they did not express PDGF-B mRNA or proliferate in low serum containing medium as do neonatal cells. A10 cells had several characteristics in common with neointimal cells including the expression of alpha-actin, vimentin, and non-muscle myosin and the lack of expression of PDGF-B mRNA as well as the ability to migrate in response to PDGF-BB. CONCLUSION: In conclusion, A10 cells are nondifferentiated VSMC that differ from neonatal but bear significant resemblance to neointimal cells.
Authors: Bo Liu; Evan Joseph Ryer; Rishi Kundi; Kentaro Kamiya; Hiroyuki Itoh; Peter L Faries; Kenji Sakakibara; K Craig Kent Journal: J Vasc Surg Date: 2007-01 Impact factor: 4.268
Authors: Jeremy W Duncan; Subhi Talal Younes; Emily Hildebrandt; Michael J Ryan; Joey P Granger; Heather A Drummond Journal: Am J Physiol Heart Circ Physiol Date: 2020-03-13 Impact factor: 4.733
Authors: Jillian E Tengood; Ivan S Alferiev; Kehan Zhang; Ilia Fishbein; Robert J Levy; Michael Chorny Journal: Proc Natl Acad Sci U S A Date: 2014-03-03 Impact factor: 11.205
Authors: Mark R Battig; Ilia Fishbein; Robert J Levy; Ivan S Alferiev; David Guerrero; Michael Chorny Journal: Drug Deliv Transl Res Date: 2018-08 Impact factor: 4.617
Authors: Kentaro Kamiya; Kenji Sakakibara; Evan J Ryer; Raymond P Hom; Edward B Leof; K Craig Kent; Bo Liu Journal: Mol Cell Biol Date: 2007-02-26 Impact factor: 4.272
Authors: Jia Ruan; Min Luo; Chunjie Wang; Lei Fan; Shao Ning Yang; Mariano Cardenas; Huimin Geng; John P Leonard; Ari Melnick; Leandro Cerchietti; Katherine A Hajjar Journal: Blood Date: 2013-04-30 Impact factor: 22.113